Vicki Sato, a director at Vir Biotechnology, has executed a sale of company stock valued at $221,025. This transaction was disclosed in a filing with the U.S. Securities and Exchange Commission. The sale is part of Sato's ongoing management of her investment portfolio, reflecting standard practices among corporate executives.
Related Articles
Don't miss out on breaking stories and in-depth articles.